Avid Bioservices Inc (CDMO)

[Tandberg1]

It could be that yesterday's surge was based on the Cotara news after all. Cotara seemed to be on the back burner. Now we hear that not only is the U.S. trial near completion, but that a paper has been selected for oral presentation at an important radiology conference. To be accepted, the results obtained obtained so far must be exceptional -- like the Bavi results we will hear about at ASCO next week.

No doubt PPHM will be meeting with potential Cotara partners at the radiology conference, just as they will be meeting with potential Bavi partners at ASCO next week.

I think this is an exciting time to be invested in PPHM stock.